January 23, 2023 –– One of the world’s starring diabetes experts, Matthias von Herrath, M.D., has been named the caller technological manager of the Diabetes Research Institute (DRI) astatine the University of Miami Miller School of Medicine. He takes implicit the pb presumption of the Institute that is among the apical successful the world, focused connected cure-based probe and advancing the integration of medicine and technology.
“I look guardant to advancing the Institute’s ngo of accelerating curing benignant 1 diabetes,” said Dr. von Herrath, who volition clasp the Stacy Joy Goodman Chair. “Recent studies constituent to promising caller directions successful diabetes probe astatine the technological and objective levels. It has ne'er been a much breathtaking time!”
Dr. von Herrath joins the Miller School aft serving arsenic prof astatine the La Jolla Institute for Immunology successful San Diego. He besides is vice president and elder aesculapian serviceman for Novo Nordisk, Inc., a Danish pharmaceutical company. He brings much than 25 years of dedicated probe into diabetes and was doubly ranked arsenic the “#1 Juvenile Diabetes Expert” by Expertscape. Dr. von Herrath was the recipient of American Diabetes Association’s outstanding technological accomplishment grant successful 2008, the German Diabetes Society’s Langerhans grant successful 2014, and besides received a beingness accomplishment grant from The Network for Pancreatic Organ Donors with Diabetes (nPOD).
“We invited Dr. von Herrath arsenic an innovative person who volition thrust the DRI’s collaborative, fast-track attack to advancing cutting-edge disciplines with a existent imaginable to present a cure for benignant 1 diabetes,” said Henri R. Ford, M.D., M.H.A., dean and main world serviceman of the Miller School. “Like the remainder oregon our team, helium is committed to the objective translation of immune-based interventions into leading-edge diligent care.”
With a unit of 90, including 21 full-time faculty, the DRI has a singular absorption connected discovering a biologic cure for benignant 1 diabetes. The Institute’s multidisciplinary squad includes researchers, engineers, and clinicians, arsenic good arsenic a big of planetary partners. “Dr. von Herrath is an experienced, visionary researcher who volition proceed to beforehand diabetes probe and acquisition astatine the DRI and crossed the University,” said Roy E. Weiss, M.D., Ph.D., Kathleen & Stanley Glaser Distinguished Chair; Rabbi Morris I. Esformes Endowed Chair successful Medicine and Endocrinology; and prof and chairman, Department of Medicine.
Launching a distinguished career
A autochthonal of Germany, Dr. von Herrath earned his aesculapian grade successful 1988 from Freiburg Medical School, wherever helium besides completed a Ph.D. equivalent thesis connected biochemistry. His postdoctoral grooming included an intensive attraction residency astatine Diakonie Hospital, Freiburg; a fellowship successful medicine/immunology astatine Freiburg Medical Center; and a fellowship successful virology astatine Scripps Research Institute successful La Jolla, California.
Dr. von Herrath joined Scripps Research Institute successful 1995 arsenic a elder probe associate, became adjunct and subordinate prof successful 1996, and joined La Jolla Institute successful 2001, wherever helium founded the Center for benignant 1 diabetes to assistance patients with the disease. “I got into benignant 1 diabetes probe due to the fact that I truly thought it mightiness beryllium a occupation that we tin tackle successful our lifetime,” helium said.
In 2012 helium joined Novo Nordisk, gathering up their Seattle R&D T1D halfway successful bid to beforehand promising therapies to the clinic. He is presently a subordinate of the company’s planetary main aesculapian bureau team. “The astir important position erstwhile processing caller preventions oregon cures for benignant 1 diabetes is that of the diligent and to amended conscionable the patient’s needs” helium said, “and bridging betwixt world probe and manufacture improvement tin greatly accelerate our ngo for a cure”.
As an early-stage researcher, Dr. von Herrath received a fellowship and a vocation improvement grant from the Juvenile Diabetes Foundation. More caller honors see the Grotzky Award and Scholar Award from the Juvenile Diabetes Foundation; the George Köhler Award from the German Society of Immunology.
Advancing diabetes research
For much than a decade, Dr. von Herrath has been main researcher for a survey funded by a National Institutes of Health (NIH) assistance connected “Specificity, Phenotype and Function of Pancreatic CD8 T Cells successful Human Type-1 Diabetes.” He besides received an NIH probe assistance for a study, “Integrated Functional Histopathology of the Diabetic Human Pancreas.”
With Novo Nordisk, helium conducted the archetypal palmy ample recent-onset T1D (type 1 diabetes) proceedings successful adults and developed an antigenic vaccine to induce tolerance to islets which is present successful signifier 1 objective studies unneurotic with Trialnet.
Fromm 2016-2017, Dr. von Herrath was the radical main researcher for a University of Miami Miller School survey to enactment the Network for Pancreatic Organ Donors with Diabetes (nPOD) and its strategy to usage squad subject and quality samples to recognize the causes and improvement of benignant 1 diabetes. The survey was funded by the Helmsley Charitable Trust and received The George S. Eisenbarth nPOD Award for Team Science.
“Dr. von Herrath has consistently demonstrated excellence successful collaborative research,” said Stephen D. Nimer, M.D., enforcement dean for research, director, Sylvester Comprehensive Cancer Center; Oscar de la Renta Endowed Chair successful Cancer Research and prof of medicine, biochemistry & molecular biology. “He volition efficaciously leverage the already divers and affluent probe assets astatine the Miller School and beforehand translational probe towards uncovering a cure for Type-1 diabetes.”
Dr. von Herrath has written oregon co-authored much than 120 peer-reviewed articles, and serves arsenic subordinate exertion for the diary Science Advances and Journal of Autoimmunity. He is simply a subordinate of the American Society for Clinical Investigation, American Society for Microbiology, American Association of Immunologists, Juvenile Diabetes Foundation International and galore different nonrecreational organizations.
Reflecting connected Dr. von Herrath’s appointment, Camillo Ricordi, M.D., DRI manager emeritus who is present advancing to a caller position, starring large planetary objective trials of pancreatic islets and stem cell-derived insulin producing compartment transplants, with the nonsubjective to destruct anti-rejection drugs, said, “Matthias’ innovative probe and achievements person contributed immensely to our cognition of diabetes. His expertise and unparalleled acquisition is highly synergistic with our enactment successful biologic replacement strategies. He is the perfect person for increasing the Institute’s broad probe portfolio towards the adjacent quantum leaps successful the hunt of a cure for this devastating disease.”
When not engaged successful probe oregon world pursuits, Dr. von Herrath enjoys playing the violin, blues and stone guitar, bicycling and spending clip with his family.
Post Views: 3
English (US)